A detailed history of Family Firm, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Family Firm, Inc. holds 6,615 shares of MRK stock, worth $844,867. This represents 0.21% of its overall portfolio holdings.

Number of Shares
6,615
Previous 6,581 0.52%
Holding current value
$844,867
Previous $717,000 21.62%
% of portfolio
0.21%
Previous 0.18%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

BUY
$113.24 - $131.95 $3,850 - $4,486
34 Added 0.52%
6,615 $872,000
Q4 2023

Feb 05, 2024

BUY
$100.18 - $109.02 $3,606 - $3,924
36 Added 0.55%
6,581 $717,000
Q3 2023

Oct 19, 2023

BUY
$102.95 - $114.33 $3,603 - $4,001
35 Added 0.54%
6,545 $673,000
Q2 2023

Aug 08, 2023

BUY
$108.61 - $118.38 $3,584 - $3,906
33 Added 0.51%
6,510 $751,000
Q1 2023

May 01, 2023

BUY
$102.94 - $114.86 $3,294 - $3,675
32 Added 0.5%
6,477 $689,000
Q4 2022

Feb 07, 2023

BUY
$87.44 - $112.11 $11,192 - $14,350
128 Added 2.03%
6,445 $714,000
Q3 2022

Nov 15, 2022

SELL
$84.53 - $94.96 $323,411 - $363,316
-3,826 Reduced 37.72%
6,317 $544,000
Q2 2022

Dec 01, 2022

BUY
$83.49 - $94.64 $330,620 - $374,774
3,960 Added 62.69%
10,277 $937,000
Q1 2022

Nov 30, 2022

BUY
$73.51 - $82.4 $282,278 - $316,416
3,840 Added 60.79%
10,157 $833,000
Q3 2021

Oct 22, 2021

BUY
$71.68 - $78.83 $25,876 - $28,457
361 Added 3.69%
10,143 $822,000
Q2 2021

Jul 21, 2021

BUY
$70.31 - $77.77 $1,406 - $1,555
20 Added 0.2%
9,782 $761,000
Q4 2020

Jan 20, 2021

BUY
$71.77 - $79.65 $36,602 - $40,621
510 Added 5.51%
9,762 $814,000
Q3 2020

Nov 04, 2020

SELL
$73.18 - $82.95 $40,980 - $46,452
-560 Reduced 5.71%
9,252 $767,000
Q2 2020

Aug 10, 2020

BUY
$70.42 - $80.13 $563 - $641
8 Added 0.08%
9,812 $759,000
Q1 2020

Apr 29, 2020

SELL
$63.36 - $87.82 $26,231 - $36,357
-414 Reduced 4.05%
9,804 $754,000
Q4 2019

Feb 04, 2020

SELL
$77.58 - $87.54 $305,820 - $345,082
-3,942 Reduced 27.84%
10,218 $929,000
Q3 2019

Nov 12, 2019

BUY
$76.08 - $82.93 $532 - $580
7 Added 0.05%
14,160 $1.19 Million
Q2 2019

Aug 06, 2019

BUY
$69.84 - $81.59 $558 - $652
8 Added 0.06%
14,153 $1.19 Million
Q1 2019

May 06, 2019

BUY
$69.58 - $79.36 $556 - $634
8 Added 0.06%
14,145 $1.18 Million
Q4 2018

Feb 05, 2019

BUY
$65.24 - $75.71 $521 - $605
8 Added 0.06%
14,137 $1.08 Million
Q3 2018

Oct 31, 2018

SELL
$57.69 - $67.84 $13,672 - $16,078
-237 Reduced 1.65%
14,129 $1 Million
Q2 2018

Aug 03, 2018

SELL
$50.83 - $59.72 $4,422 - $5,195
-87 Reduced 0.6%
14,366 $872,000
Q1 2018

Apr 26, 2018

BUY
$50.96 - $59.23 $3,312 - $3,849
65 Added 0.45%
14,453 $787,000
Q4 2017

Feb 07, 2018

SELL
$51.62 - $61.64 $27,255 - $32,545
-528 Reduced 3.54%
14,388 $810,000
Q3 2017

Nov 07, 2017

SELL
$58.67 - $63.13 $2,346 - $2,525
-40 Reduced 0.27%
14,916 $955,000
Q2 2017

Aug 08, 2017

BUY
N/A
14,956
14,956 $959,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $324B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Family Firm, Inc. Portfolio

Follow Family Firm, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Family Firm, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Family Firm, Inc. with notifications on news.